CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-22 | Eansor Norman David President-Protein Sciences | Option exercise | +3,963 | $94.35 | $374K | 3,963 |
| 2020-05-22 | Eansor Norman David President-Protein Sciences | Option exercise | +8,637 | $108.49 | $937K | 12,600 |
| 2020-05-22 | Eansor Norman David President-Protein Sciences | Sale | −7,676 | $267.63 | $2.1M | 4,924 |
| 2020-05-22 | Eansor Norman David President-Protein Sciences | Sale | −4,924 | $268.41 | $1.3M | 0 |
| 2020-05-22 | Eansor Norman David President-Protein Sciences | Option exercise · Stock Options (Right to Buy) | −3,963 | 0 | ||
| 2020-05-22 | Eansor Norman David President-Protein Sciences | Option exercise · Stock Options (Right to Buy) | −8,637 | 11,357 | ||
| 2020-05-21 | Eansor Norman David President-Protein Sciences | Option exercise | +11,037 | $94.35 | $1.0M | 11,037 |
| 2020-05-21 | Eansor Norman David President-Protein Sciences | Sale | −10,137 | $267.37 | $2.7M | 900 |
| 2020-05-21 | Eansor Norman David President-Protein Sciences | Sale | −900 | $268.89 | $242K | 0 |
| 2020-05-21 | Eansor Norman David President-Protein Sciences | Option exercise · Stock Options (Right to Buy) | −11,037 | 3,963 | ||
| 2020-05-21 | BAUMGARTNER ROBERT V Director | Option exercise | +5,000 | $70.35 | $352K | 14,221 |
| 2020-05-21 | BAUMGARTNER ROBERT V Director | Sale | −1,300 | $265.35 | $345K | 12,921 |
| 2020-05-21 | BAUMGARTNER ROBERT V Director | Sale | −1,601 | $266.07 | $426K | 11,320 |
| 2020-05-21 | BAUMGARTNER ROBERT V Director | Sale | −1,974 | $267.32 | $528K | 9,346 |
| 2020-05-21 | BAUMGARTNER ROBERT V Director | Sale | −125 | $267.94 | $33K | 9,221 |
| 2020-05-21 | BAUMGARTNER ROBERT V Director | Option exercise · Stock Options (right to Buy) | −5,000 | 0 | ||
| 2020-05-06 | WIENS HAROLD J Director | Option exercise | +4,260 | $87.34 | $372K | 9,481 |
| 2020-05-06 | WIENS HAROLD J Director | Sale | −4,260 | $250.00 | $1.1M | 5,221 |
| 2020-05-06 | WIENS HAROLD J Director | Option exercise · Stock Option (right to buy) | −4,260 | 0 | ||
| 2020-05-01 | Kelderman Kim Pres. Diagnostics & Genom | Option exercise | +1,666 | 2,489 |
Page 45 of 53 · 1,043 trades